FDA approves J&J's Stelara

Johnson & Johnson (NYSE:JNJ) subsidiary Centocor Ortho Biotech received FDA approval for a BLA for Stelara ustekinumab to treat adults with moderate to severe plaque psoriasis who are candidates for p...